benzopyranoperidine

has significant intraocular pressure lowering effect; tetrahydropyridobenzopyran derived from cannabinoid; RN given refers to parent cpd; structure

Also Known As:

Abbott 40656; BW146Y; benzopyranoperidine dihydrochloride; benzopyranoperidine monohydrochloride

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

1.	Chronic Pain 08/01/1978 - "In a double-blind, 5-way crossover designed study, single doses of placebo, 2 doses of codeine sulfate (60 and 120 mg), and 2 doses of benzopyranoperidine (2 and 4 mg) were administered orally to 35 patients who required analgesics for chronic pain due to malignancies. "
2.	Neoplasms (Cancer) 08/01/1978 - "In a double-blind, 5-way crossover designed study, single doses of placebo, 2 doses of codeine sulfate (60 and 120 mg), and 2 doses of benzopyranoperidine (2 and 4 mg) were administered orally to 35 patients who required analgesics for chronic pain due to malignancies. "
3.	Pain (Aches) 08/01/1978 - "Effect of benzopyranoperidine, a delta-9-THC congener, on pain."

1.	Sulfates (Sulfates, Inorganic)
2.	Codeine (Codeine Phosphate)
3.	Analgesics (Analgesic Drugs)